Município de Jundiaí, SMPS - Secretaria Municipal de Promoção da Saúde, Jundiaí (SP)

Azatioprina 50MG, formoterol fumarato + budesonida 12/400 MGC e outros - MJ - RP.

Publicado em 01/04/2026.

Itens

• Cota Principal - AZATIOPRINA 50 MG
• Cota Reservada - AZATIOPRINA 50 MG
• Cota principal - formoterol fumarato + budesonida 12/400 MCG
• Cota reservada - formoterol fumarato + budesonida 12/400 MCG
• Cota principal - ranibizumabe 10MG/ML solucao injetavel com 0,23 ML
• Cota reservada - ranibizumabe 10MG/ML solucao injetavel com 0,23 ML
• Cota Principal - PIRIDOSTIGMINA BROMETO 60MG
• Cota Reservada - PIRIDOSTIGMINA BROMETO 60MG
• Cota principal - salmeterol 50MCG + fluticasona 500MCG po inalante 60 doses
• Cota reservada - salmeterol 50MCG + fluticasona 500MCG po inalante 60 doses
• Cota principal - salmeterol 50MCG + fluticasona 250MCG po inalante 60 doses
• Cota reservada - salmeterol 50MCG + fluticasona 250MCG po inalante 60 doses
• Cota Principal - FLUVOXAMINA MALEATO 100MG
• Cota Reservada - FLUVOXAMINA MALEATO 100MG
• Cota Principal - LINAGLIPTINA 5MG
• Cota Reservada - LINAGLIPTINA 5MG
• Cota principal - fluticasona furoato 27,5MCG spray nasal 120 doses
• Cota reservada - fluticasona furoato 27,5MCG spray nasal 120 doses
• Cota Principal - ALOGLIPTINA 25MG
• Cota Reservada - ALOGLIPTINA 25MG
• Cota principal - dapagliflozina 5MG + metformina cloridrato 1000MG
• Cota reservada - dapagliflozina 5MG + metformina cloridrato 1000MG
• Cota principal - formoterol fumarato + budesonida 6/200MCG suspensao aerossol
• Cota reservada - formoterol fumarato + budesonida 6/200MCG suspensao aerossol
• Cota principal - sacubitril 97 MG + valsartana 103 MG
• Cota reservada - sacubitril 97 MG + valsartana 103 MG
• Cota principal - dapagliflozina 10 MG + metformina cloridrato 1000 MG libera
• Cota reservada - dapagliflozina 10 MG + metformina cloridrato 1000 MG libera
• Cota principal - dupilumabe 200MG sol injetavel seringa preenchida com 1,14ML
• Cota reservada - dupilumabe 200MG sol injetavel seringa preenchida com 1,14ML
• Cota principal - omalizumabe solucao injetavel 150 mg/ml
• Cota reservada - omalizumabe solucao injetavel 150 mg/ml
• Cota principal - ustequinumabe solucao injetavel 90 mg/ml - seringa com 1 ML
• Cota reservada - ustequinumabe solucao injetavel 90 mg/ml - seringa com 1 ML

Quem vendeu